l

The content of this website is intended for healthcare professionals only

Previous Posts

1 2 

Tick-borne encephalitis

Evidence-based medicine

Gerry Morrow

Tuesday, 19 November 2019

AdobeStock_154750843_tick_blog.jpgThe size of the problem 

Encephalitis is an acute inflammation of the brain, which can cause serious illness and death. The prevalence of encephalitis has proven difficult to ascertain, due to diagnostic and coding challenges, but recent estimates suggest 5.23 cases per 100,000 population per year. Viral causes predominate, with herpes simplex being the commonest aetiology. However, in up to 60% of all cases of encephalitis in the UK, there is no specific cause delineated.  

Tick-borne encephalitis (TBE) 

The tick-borne encephalitis virus is an RNA flavivirus, which can cause a potentially fatal and untreatable neurological infection across Europe and Asia. The diagnosis of TBE in this area has increased by over 400% since the 1970s. It is thought that some of this increase is as a result of increased vigilance and suspicion of the disease, but also as result of an increase in the tick population and in changing patterns of human behaviour, resulting in greater exposure to ticks. These behaviours include hiking and fishing in affected areas.  

A rising prevalence 

The question which inevitably arises from this increased prevalence is 'why has the tick population risen?' 

The answer appears to be one comprising elements of changes in land use, increased transportation of animals, and increased co-feeding by nymphs and larvae on the same rodent host. The extent to which this co-feeding occurs depends upon the patterns of seasonal host activity, which is influenced by ambient environmental temperature.  

Influence of global warming 

The apparent increase in incidence of TBE over the last five decades has therefore been attributed to climate change, which affects both tick and host rodent and other mammalian population dynamics. 

New evidence of zoonotic pool of disease 

Recent evidence of an increase in the potential TBE viral pool in the UK has emerged in the Thetford Forest area. In summer 2019, a single case of TBE was acquired in the New Forest area. As a result, a study was undertaken by Public Health England and the Emerging and Zoonotic Infections National Institute for Health Research, University of Liverpool to look at the prevalence of tick-borne encephalitis virus in the likely host organisms in this area.  

Their results included a finding that almost 48% of deer in the Thetford Forest area were seropositive for TBE virus. They concluded that “this detection of TBEV genomic sequence in UK ticks has important public health implications, especially for undiagnosed encephalitis”. 

What could happen next? 

Although most TBE infections in the UK are imported, the finding of a high incidence of TBE seropositivity in deer and a case of UK acquired TBE is cause for concern. A similar pattern of disease expansion occurred in South Korea some years ago with the consequence of increasing TBE prevalence and the fact that it is now a notifiable disease.  

With the further advance of global warming it is therefore possible that tick-borne encephalitis could become a more common pathogen in the UK and should be considered by clinicians in areas of risk.  


Related content
  • Tick-born encephalitis virus detected in ticks in UK. OnMedica news, 2019.
  • Lyme disease. OnMedica case history covering tick management, usual presentation, diagnosis, treatment and indications for hospital admiss

Author's Image

Gerry Morrow

With a keen interest in evidence-based medicine and patient involvement, Gerry has over twenty years’ experience working as a GP, based initially in Worcester and then in the rural practice of Allendale. Now Medical Director of Clarity Informatics, a leading IT healthcare solutions provider, Gerry is leading a globally recognised team of clinicians and researchers, and is also directly responsible for the production and delivering of Clarity’s clinical guidance which forms the clinical content of NICE’s Clinical Knowledge Summaries (CKS) service. Gerry is also a clinical non-executive director of the North East Ambulance Service, responsible for operating patient transport and ambulance response services across a region covering 3,200 square miles and a population of 2.7 million people.
Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470